Acute cholestatic hepatitis along with agranulocytosis

A rare side effect of carbimazole

Karun Jain, M. Chakrapani, K. Smitha

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life-threatening side effects such as agranulocytosis, aplastic anemia and cholestatic hepatitis. A 45-year-old female was diagnosed with severe hyperthyroidism. Treatment with Carbimazole 30 mg/day was initiated. Within six weeks following the start of therapy, patient developed potentially life-threatening acute cholestatic hepatitis and agranulocytosis as adverse effects to carbimazole. The patient's symptoms and laboratory abnormalities resolved following withdrawal of offending drug. Agranulocytosis and cholestatic hepatitis together is an extremely rare idiosyncratic side effect of Carbimazole treatment and considered to be dose and age-related. Antithyroid drugs are deceptively easy to use, but because of the variability in the response of patients and the potentially serious side effects, all practitioners who prescribe the drugs need to have a working knowledge of their complex pharmacology.

Original languageEnglish
Pages (from-to)102-104
Number of pages3
JournalAnnals of African Medicine
Volume9
Issue number2
DOIs
Publication statusPublished - 01-06-2010

Fingerprint

Carbimazole
Agranulocytosis
Hepatitis
Antithyroid Agents
Hyperthyroidism
Aplastic Anemia
Therapeutics
Pharmaceutical Preparations
Pharmacology

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{d1e50a1ccd354d67b44fd164ecf29e8e,
title = "Acute cholestatic hepatitis along with agranulocytosis: A rare side effect of carbimazole",
abstract = "Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life-threatening side effects such as agranulocytosis, aplastic anemia and cholestatic hepatitis. A 45-year-old female was diagnosed with severe hyperthyroidism. Treatment with Carbimazole 30 mg/day was initiated. Within six weeks following the start of therapy, patient developed potentially life-threatening acute cholestatic hepatitis and agranulocytosis as adverse effects to carbimazole. The patient's symptoms and laboratory abnormalities resolved following withdrawal of offending drug. Agranulocytosis and cholestatic hepatitis together is an extremely rare idiosyncratic side effect of Carbimazole treatment and considered to be dose and age-related. Antithyroid drugs are deceptively easy to use, but because of the variability in the response of patients and the potentially serious side effects, all practitioners who prescribe the drugs need to have a working knowledge of their complex pharmacology.",
author = "Karun Jain and M. Chakrapani and K. Smitha",
year = "2010",
month = "6",
day = "1",
doi = "10.4103/1596-3519.64752",
language = "English",
volume = "9",
pages = "102--104",
journal = "Annals of African Medicine",
issn = "1596-3519",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

Acute cholestatic hepatitis along with agranulocytosis : A rare side effect of carbimazole. / Jain, Karun; Chakrapani, M.; Smitha, K.

In: Annals of African Medicine, Vol. 9, No. 2, 01.06.2010, p. 102-104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Acute cholestatic hepatitis along with agranulocytosis

T2 - A rare side effect of carbimazole

AU - Jain, Karun

AU - Chakrapani, M.

AU - Smitha, K.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life-threatening side effects such as agranulocytosis, aplastic anemia and cholestatic hepatitis. A 45-year-old female was diagnosed with severe hyperthyroidism. Treatment with Carbimazole 30 mg/day was initiated. Within six weeks following the start of therapy, patient developed potentially life-threatening acute cholestatic hepatitis and agranulocytosis as adverse effects to carbimazole. The patient's symptoms and laboratory abnormalities resolved following withdrawal of offending drug. Agranulocytosis and cholestatic hepatitis together is an extremely rare idiosyncratic side effect of Carbimazole treatment and considered to be dose and age-related. Antithyroid drugs are deceptively easy to use, but because of the variability in the response of patients and the potentially serious side effects, all practitioners who prescribe the drugs need to have a working knowledge of their complex pharmacology.

AB - Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life-threatening side effects such as agranulocytosis, aplastic anemia and cholestatic hepatitis. A 45-year-old female was diagnosed with severe hyperthyroidism. Treatment with Carbimazole 30 mg/day was initiated. Within six weeks following the start of therapy, patient developed potentially life-threatening acute cholestatic hepatitis and agranulocytosis as adverse effects to carbimazole. The patient's symptoms and laboratory abnormalities resolved following withdrawal of offending drug. Agranulocytosis and cholestatic hepatitis together is an extremely rare idiosyncratic side effect of Carbimazole treatment and considered to be dose and age-related. Antithyroid drugs are deceptively easy to use, but because of the variability in the response of patients and the potentially serious side effects, all practitioners who prescribe the drugs need to have a working knowledge of their complex pharmacology.

UR - http://www.scopus.com/inward/record.url?scp=77954786638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954786638&partnerID=8YFLogxK

U2 - 10.4103/1596-3519.64752

DO - 10.4103/1596-3519.64752

M3 - Article

VL - 9

SP - 102

EP - 104

JO - Annals of African Medicine

JF - Annals of African Medicine

SN - 1596-3519

IS - 2

ER -